Siegmund T, Usadel K H, Donner H, Braun J, Walfish P G, Badenhoop K
Medical Department I, Centre of Internal Medicine, Klinikum of the J. W. Goethe-University, Frankfurt/Main, Germany.
Thyroid. 1998 Nov;8(11):1013-7. doi: 10.1089/thy.1998.8.1013.
Although some of the susceptibility to Graves' disease is conferred by genes in the human leucocyte antigen (HLA) region on the short arm of chromosome 6, other genetic factors must also predispose. Among the cytokines involved in thyroid autoimmunity interferon-gamma (IFN-gamma) plays a key role in the pathogenesis of Graves' disease. We therefore analyzed the first intron of the IFN-gamma gene for a dinucleotide (CA) repeat polymorphism on chromosome 12q. Two hundred two Caucasian patients with Graves' disease and 214 Caucasian controls were analyzed by polymerase chain reaction (PCR) and subsequent polyacrylamide gel electrophoresis technique: eight different alleles designated as IFN-gamma1 to IFN-gamma8 could be differentiated. Among Graves' disease patients IFN-gamma5 (12.9% vs. 6.8%, p < 0.04) was significantly more frequent whereas IFN-gamma2 (2.5% vs. 9.8%, p < 0.002) was significantly less frequent. Patients positive for the genetic susceptibility marker HLA DQA10501 had significantly more IFN-gamma3 alleles (13.6% vs. 2.6%, p < 0.009) and IFN-gamma5 alleles (22.1% vs. 7.6%, p < 0.03) compared with DQA10501 positive controls. Also, among patients with endocrine ophthalmopathy IFN-gamma3 (17.9% vs. 4.2%, p < 8 x 10(-6)) and IFN-gamma5 (18.9% vs. 7.0%, p < 0.003) were significantly more frequent compared with controls. Although a significant association of IFN-gamma microsatellite polymorphism was observed, only a small proportion of Graves' disease patients have these markers. Thus, it is likely that the detected microsatellite polymorphisms play only a minor role in the susceptibility to Graves' disease.
